Bangkok Dusit Medical Services Public Co., Ltd.
 
 
 
 
公司概覽
業務類別 --
業務概覽 Bangkok Dusit Medical Services PCL operates a network of hospitals throughout Thailand under the Bangkok Hospital, Phyathai Hospital, Samitivej Hospital, Paolo Hospital, BNH Hospital, and Royal International Hospital brands. The company has two business segments namely, hospital operations and other businesses that support hospital business such as medical laboratories, production and distribution of pharmaceutical products/medical equipment/saline, pharmacies, assets management for healthcare business, accounting services, technology and information services, training business and insurance broker. The company's hospital operations generate the vast majority of its revenue.
公司地址 New Petchburi Road, 2, Soi Soonvijai 7, Bang Kapi, Huaykwang, Bangkok, THA, 10310
電話號碼 +66 23103000
傳真號碼 +66 23181546
公司網頁 https://www.bdms.co.th
員工數量 57370
 
公司高管 / 董事會成員
公司高管
高管 職務 年薪 更新日期
Mr. Sripop Sarasas Director and Chief Administrative Officer -- 13/03/2025
Ms. Narumol Noi-Am Director, Senior Executive Vice President and Chief Financial Officer -- 13/03/2025
Dr. Poramaporn Prasarttong-Osoth, M.D. Director, President and Senior Chief Executive Officer, Group 1 -- 13/03/2025
Dr. Chairat Panthuraamphorn, M.D. Director and Chief Operating Officer -- 13/03/2025
Mr. Att Thongtang Director and Chief Executive Officer, Group 5 -- 13/03/2025
 
董事會成員
董事會 職務 更新日期
Mr. Kan Trakulhoon Independent Director 13/03/2025
Mr. Predee Daochai Independent Director 13/03/2025
Mr. Veerathai Santiprabhob Independent Director 13/03/2025
Mr. Thongchai Jira-alongkorn Director 13/03/2025
Professor Piyasakol Sakolsatayadorn, M.D. Director 13/03/2025
Mr. Subhak Siwaraksa, PhD Independent Director 13/03/2025
Mr. Sripop Sarasas Director and Chief Administrative Officer 13/03/2025
Mr. Pradit Theekakul Director 13/03/2025
Ms. Narumol Noi-Am Director, Senior Executive Vice President and Chief Financial Officer 13/03/2025
Mr. Chuladej Yossundharakul, M.D. Vice Chairman of the Board 13/03/2025
Dr. Poramaporn Prasarttong-Osoth, M.D. Director, President and Senior Chief Executive Officer, Group 1 13/03/2025
Dr. Santasiri Sornmani, M.D.,PhD Chairman of the Board 13/03/2025
Mr. Chavalit Sethameteekul Independent Director 13/03/2025
Dr. Chairat Panthuraamphorn, M.D. Director and Chief Operating Officer 13/03/2025
Mr. Att Thongtang Director and Chief Executive Officer, Group 5 13/03/2025
Mr. Puttipong Prasarttong-Osoth Director 13/03/2025
 
所屬ETF (更新日期: 07/03/2026 04:17)
代號 名稱 佔比% 持有日期
FLAXFranklin FTSE Asia ex Japan ETF0.0003%28/02/2026
TLTEFlexShares Mstar EmgMkts FctTilt ETF0.0002%27/02/2026
PBEEInvesco PureBeta FTSE Emerging Mkts ETF0.0002%31/05/2023
REMGSPDR Bloomberg SASB EM ESG Slct ETF0.0001%31/03/2023
XCNYState Street® SPDR® S&P EM ex-China ETF0.00002%27/02/2026
AOMiShares Core 40/60 Moderate Allc ETF<0.000001%27/02/2026
CRBNiShares Low Carbon Optd MSCI ACWI ETF<0.000001%28/02/2026
DEHPDimensional Em Mkts High Prof ETF<0.000001%27/08/2025
DEXCDimensional Em Mkts ex China Cr Eq ETF<0.000001%05/12/2025
DFAEDimensional Emerging Core Equity Mkt ETF<0.000001%05/12/2025
DFAXDimensional World ex US Core Eq 2 ETF<0.000001%05/12/2025
DFEMDimensional Emerging Markets Cr Eq 2 ETF<0.000001%05/12/2025
DFSEDimensional Emerging Mrkts Sstby Cr 1ETF<0.000001%05/12/2025
EMCGlobal X Emerging Mkts Great Cnsmr ETF<0.000001%17/06/2025
EMMGlobal X Emerging Markets ex-China ETF<0.000001%17/07/2025
HAWXiShares Currency Hdgd MSCI ACWI exUS ETF<0.000001%26/02/2026
HEEMiShares Currency Hedged MSCI Em Mkts ETF<0.000001%28/02/2026
IDEQLazard International Dynamic Equity ETF<0.000001%03/07/2025
REMGRussell Inv Emerging Markets Equity ETF<0.000001%12/11/2025
RODEHartford Multifactor Divers Intl ETF<0.000001%11/06/2025
  1    2   3    4  
 

Copyright © 2026 ET Net Limited.
All rights reserved. Use of this site signifies your agreement to the terms of use.
DISCLAIMER: ET Net Limited and Third Party Information Providers endeavour to ensure the accuracy and reliability of the information provided, but do not guarantee its accuracy and reliability and accept no liability (whether in tort or contract or otherwise) for any loss or damage arising from any inaccuracies or omissions.